Silencing of MEG3 resulted in a proangiogenic effect through upregulation of Notch pathway-related genes in both ischemia brains and endothelial cells, leading to enhanced functional recovery and reducing the focal ischemia volume after a stroke [84]. The gene discussed is MEG3; the disease is Stroke.